TenaTac® is used during and after surgical procedures to achieve local haemostasis by tamponade effect.

TenaTac® has a unique, patented* surface modification created with high precision. The surface of the patch is divided into over 1000 columns. This leads to a 10-fold increase in surface area, greatly increasing the interaction between the product and the underlying tissue. The flexible columns conform to the variations in tissue surface and act independently to resist shear forces that may dislodge a normal sponge in the peri-operative period.

For various video about TenaTac View Here

Alongside our own-brand ranges, Mediq is proud to hold exclusive UK distribution partnerships with leading national and international manufacturers. These trusted collaborations bring high-performing products into the hands of UK healthcare professionals through Mediq’s reliable, nationwide network.

Developed by Selentus Science, TenaTac® began as a scientific vision to solve a real surgical challenge: achieving fast, reliable haemostasis that can adapt to the natural movement of the body, particularly in the lungs. Using advanced material science, the Selentus team created a flexible, adhesive and rapidly absorbable patch designed to perform where traditional solutions fall short. Their patented micro‑column structure and surface‑modified gelatine technology enable secure, evenly distributed adhesion, even on complex, uneven, or moving anatomical surfaces.

Turning this innovation into a product surgeons can depend on requires the strength of a coordinated partnership. CuraMedical B.V. manufactures every TenaTac® patch with precision and consistency, while CuraMedrix B.V. oversees global commercial distribution to ensure that healthcare systems worldwide have reliable access to this breakthrough technology.